| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |